Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The primary goal of the analysis is to estimate the diagnostic accuracy of Gallium 68 (68Ga)
-DOTATOC PET/CT for detecting neuroendocrine tumors (NETs) compared to conventional imaging
techniques such as Magnetic Resonance Imaging (MRI) and Computerized Tomography (CT).
Participants with histologically and/or clinically confirmed and/or suspected NET will be
enrolled.